Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.310
-0.040 (-2.96%)
At close: Oct 17, 2025, 4:00 PM EDT
1.320
+0.010 (0.76%)
After-hours: Oct 17, 2025, 7:59 PM EDT
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $410.75 million as of October 17, 2025. Its market cap has increased by 9.50% in one year.
Market Cap
410.75M
Enterprise Value
541.65M
1-Year Change
9.50%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $410.75M, a decrease of -92.75%. That is a compound annual growth rate of -29.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 314.20M | 8.83% |
| Dec 31, 2024 | 288.70M | -31.86% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
| May 24, 2018 | 5.67B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |